Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)

General Information of Drug (ID: DR0272)
Drug Name
Carboplatin
Synonyms
Carboplatin; Paraplatin; RL03611; 1,1-Cyclobutanedicarboxylatodiammineplatinum(II); 10329-EP2281815A1; 10329-EP2292617A1; 10329-EP2298765A1; 10329-EP2301538A1; 10329-EP2305243A1; 10329-EP2308812A2; 10329-EP2308833A2; 10329-EP2308839A1; 10329-EP2311455A1; 10329-EP2311807A1; 10329-EP2311825A1; 10329-EP2314590A1; 10329-EP2316833A1; 41575-94-4; AB01568249_01; BG3F62OND5; Cbdca; JM-8; NSC 241240; UNII-BG3F62OND5; cis-Diammine(1,1-cyclobutanedicarboxylato) platinum; cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II); s1215
Indication Ovarian cancer [ICD11: 2C73] Approved [1]
Structure
3D MOL is unavailable 2D MOL
Pharmaceutical Properties Molecular Weight 371.25 Topological Polar Surface Area 82.3
Heavy Atom Count 13 Rotatable Bond Count 0
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 6
Cross-matching ID
PubChem CID
10339178
PubChem SID
15350457 ; 22704376 ; 33972238 ; 75354552 ; 87558792 ; 117682520 ; 127293893 ; 127293894 ; 127293895 ; 127293896 ; 127293897 ; 127293898 ; 127293899 ; 127293900 ; 127293901 ; 127293902 ; 127293903 ; 127293904 ; 127293905 ; 127293906 ; 127293907 ; 127293908 ; 127293909 ; 127293910 ; 127293911 ; 127293912 ; 127293913 ; 127293914 ; 127293915 ; 127293916 ; 127293917 ; 127293918 ; 127293919 ; 127293920 ; 127293921 ; 127293922 ; 127293923 ; 127293924 ; 127293925 ; 127293926 ; 127293927 ; 127293928 ; 127293929 ; 127293930 ; 127293931 ; 127293932 ; 127293933 ; 127293934 ; 127293935 ; 127293936
ChEBI ID
ChEBI:31355
CAS Number
41575-94-4
TTD Drug ID
D0X7HM
Formula
C6H12N2O4Pt
Canonical SMILES
C1CC(C1)(C(=O)[O-])C(=O)[O-].N.N.[Pt+2]
InChI
1S/C6H8O4.2H3N.Pt/c7-4(8)6(5(9)10)2-1-3-6;;;/h1-3H2,(H,7,8)(H,9,10);2*1H3;/q;;;+2/p-2
InChIKey
OLESAACUTLOWQZ-UHFFFAOYSA-L
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Glutathione S-transferase mu-1 (GSTM1) DME0308 Homo sapiens
GSTM1_HUMAN
2.5.1.18
[2]
Glutathione S-transferase pi (GSTP1) DME0088 Homo sapiens
GSTP1_HUMAN
2.5.1.18
[2]
Glutathione S-transferase theta-1 (GSTT1) DME0093 Homo sapiens
GSTT1_HUMAN
2.5.1.18
[2]
Metallothionein-1A (MT1A) DME0094 Homo sapiens
MT1A_HUMAN
1.8.5.1
[2]
Metallothionein-2A (MT2A) DME0095 Homo sapiens
MT2_HUMAN
1.8.5.1
[2]
Myeloperoxidase (MPO) DME0096 Homo sapiens
PERM_HUMAN
1.11.2.2
[2]
Quinone reductase 1 (NQO1) DME0097 Homo sapiens
NQO1_HUMAN
1.6.5.2
[2]
Unclear metabolic mechanism (DME-unclear) DME1449 Prevotella copri Not Available Not Available [3]
⏷ Show the Full List of 8  DME(s)
References
1 Carboplatin was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration.
2 PharmGKB: A worldwide resource for pharmacogenomic information. Wiley Interdiscip Rev Syst Biol Med. 2018 Jul;10(4):e1417. (ID: PA150642262)
3 revotella copri is associated with carboplatin-induced gut toxicity. Cell Death Dis. 2019 Sep 26;10(10):714.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.